Global Compensation Manager
Alcon
Summary
The Global Compensation Manager role will lead the Annual Rewards cycle and be responsible for the development of an integrated plan that includes program deliverables, strategic alignment with HR goals, enterprise-wide impacts, milestones, risks, assumptions, constraints, change management for the program and overall program investment (PGR global budget management).
Job description
Performance, Growth & Rewards (PGR) Program Leadership
- Lead the annual global Performance, Growth & Rewards (PGR) cycle, including merit, bonus, equity, and Exceptional Nomination programs for all Alcon locations, including ATL populations.
- Manage end-to-end pay planning activities, including budget planning, cost analysis, financial controls, and global reporting in partnership with Finance.
- Prepare monthly Short-Term Incentive (STI) accruals, termination calculations, and related reporting requirements.
- Manage merit, STI, and LTI audits and data validation activities to ensure accuracy and program integrity.
- Coordinate annual salary range updates in Workday based on market data provided by Compensation Consultants.
Systems, Process & Project Management & Administration
- Gather global business and regulatory requirements and translate them into functional specifications for Workday compensation processes and enhancements.
- Support implementation and administration of compensation programs including regulatory increases, budget management, union/works council requirements, and off-cycle compensation actions.
- Troubleshoot and resolve Workday, ServiceNow (SNOW), compensation, and PGR-related system and data issues.
- Drive process improvements to enhance efficiency, compliance, and user experience.
- Ensure compliance with compensation regulations and applicable local, state, federal, and global requirements.
Governance, Audits & Compliance
- Lead compensation operations audits, regulatory reviews, and governance activities in collaboration with internal stakeholders.
- Maintain audit readiness and ensure compensation programs, processes, and reporting meet organizational and regulatory standards.
Stakeholder Partnership & Communication
- Partner with HR, Total Rewards, Finance, leadership, and business stakeholders to deliver effective compensation programs and solutions.
- Provide regular communications, project updates, risk assessments, and status reporting for PGR and broader compensation initiatives.
- Influence stakeholders and remove roadblocks related to Job Family Mapping (JFM), job catalog management, and compensation-related requests.
- Prepare retention and milestone award letters in partnership with HR Business Partners and business leaders.
Requirements
- Bachelor's Degree or Equivalent years of directly related experience (or high school +13 yrs; Assoc.+9 yrs; M.S.+2 yrs; PhD+1 yr)
- The ability to fluently read, write, understand, and communicate in English
- 5 Years of Relevant Experience
- 3 Years of Demonstrated Leadership
Benefits
- Health insurance
- Life insurance
- Retirement plan
- Flexible time off
Company overview
Alcon Inc. is the global leader in eye care, dedicated to helping people see brilliantly. Founded in 1945 as a small pharmacy in Fort Worth, Texas, the company has grown into the world's largest eye care device company with complementary businesses in Surgical and Vision Care. As a Swiss-American multinational corporation headquartered in Geneva, Switzerland with major operations in Fort Worth, Texas, Alcon operates in 60 countries and serves patients in over 140 countries. The company's Surgical segment focuses on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery, and glaucoma surgery, including implantables, consumables, and surgical equipment. The Vision Care segment comprises daily disposable, reusable, and color-enhancing contact lenses, along with a comprehensive portfolio of ocular health products for dry eye, contact lens care, and ocular allergies. With over 75 years of heritage, Alcon has a long history of industry firsts and makes substantial annual investments in research and development to meet evolving customer needs and advance patient care. The company became an independent publicly-traded entity in 2019 after spinning off from Novartis.